» Articles » PMID: 26800118

Abundant Cytomegalovirus (CMV) Reactive Clonotypes in the CD8(+) T Cell Receptor Alpha Repertoire Following Allogeneic Transplantation

Overview
Date 2016 Jan 23
PMID 26800118
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Allogeneic stem cell transplantation is potentially curative, but associated with post-transplantation complications, including cytomegalovirus (CMV) infections. An effective immune response requires T cells recognizing CMV epitopes via their T cell receptors (TCRs). Little is known about the TCR repertoire, in particular the TCR-α repertoire and its clinical relevance in patients following stem cell transplantation. Using next-generation sequencing we examined the TCR-α repertoire of CD8(+) T cells and CMV-specific CD8(+) T cells in four patients. Additionally, we performed single-cell TCR-αβ sequencing of CMV-specific CD8(+) T cells. The TCR-α composition of human leucocyte antigen (HLA)-A*0201 CMVpp65- and CMVIE -specific T cells was oligoclonal and defined by few dominant clonotypes. Frequencies of single clonotypes reached up to 11% of all CD8(+) T cells and half of the total CD8(+) T cell repertoire was dominated by few CMV-reactive clonotypes. Some TCR-α clonotypes were shared between patients. Gene expression of the circulating CMV-specific CD8(+) T cells was consistent with chronically activated effector memory T cells. The CD8(+) T cell response to CMV reactivation resulted in an expansion of a few TCR-α clonotypes to dominate the CD8(+) repertoires. These results warrant further larger studies to define the ability of oligoclonally expanded T cell clones to achieve an effective anti-viral T cell response in this setting.

Citing Articles

Elucidating the Role of the T Cell Receptor Repertoire in Myelodysplastic Neoplasms and Acute Myeloid Leukemia.

Barakos G, Georgoulis V, Koumpis E, Hatzimichael E Diseases. 2025; 13(1).

PMID: 39851483 PMC: 11765071. DOI: 10.3390/diseases13010019.


ATLAS-seq: a microfluidic single-cell TCR screen for antigen-reactive TCRs.

Luo S, Notaro A, Lin L Nat Commun. 2025; 16(1):216.

PMID: 39746936 PMC: 11696065. DOI: 10.1038/s41467-024-54675-3.


DNA methylation profiling identifies TBKBP1 as potent amplifier of cytotoxic activity in CMV-specific human CD8+ T cells.

Yu Z, Sasidharan-Nair V, Buchta T, Bonifacius A, Khan F, Pietzsch B PLoS Pathog. 2024; 20(9):e1012581.

PMID: 39325839 PMC: 11460711. DOI: 10.1371/journal.ppat.1012581.


Secretion of IFN-γ by specific T cells in HCMV infection.

Liang H, Gong S, Gui G, Wang H, Jiang L, Li X Heliyon. 2024; 10(6):e28177.

PMID: 38533049 PMC: 10963622. DOI: 10.1016/j.heliyon.2024.e28177.


Numbers and odds: TCR repertoire size and its age changes impacting on T cell functions.

Weng N Semin Immunol. 2023; 69:101810.

PMID: 37515916 PMC: 10530048. DOI: 10.1016/j.smim.2023.101810.


References
1.
Elmaagacli A, Steckel N, Koldehoff M, Hegerfeldt Y, Trenschel R, Ditschkowski M . Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood. 2011; 118(5):1402-12. DOI: 10.1182/blood-2010-08-304121. View

2.
Suessmuth Y, Mukherjee R, Watkins B, Koura D, Finstermeier K, Desmarais C . CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire. Blood. 2015; 125(25):3835-50. PMC: 4473113. DOI: 10.1182/blood-2015-03-631853. View

3.
Eugster A, Lindner A, Heninger A, Wilhelm C, Dietz S, Catani M . Measuring T cell receptor and T cell gene expression diversity in antigen-responsive human CD4+ T cells. J Immunol Methods. 2013; 400-401:13-22. DOI: 10.1016/j.jim.2013.11.003. View

4.
Matz M, Shagin D, Bogdanova E, Britanova O, Lukyanov S, Diatchenko L . Amplification of cDNA ends based on template-switching effect and step-out PCR. Nucleic Acids Res. 1999; 27(6):1558-60. PMC: 148354. DOI: 10.1093/nar/27.6.1558. View

5.
Nguyen T, Rowntree L, Pellicci D, Bird N, Handel A, Kjer-Nielsen L . Recognition of distinct cross-reactive virus-specific CD8+ T cells reveals a unique TCR signature in a clinical setting. J Immunol. 2014; 192(11):5039-49. DOI: 10.4049/jimmunol.1303147. View